Academic challenges on ATMPs’ development: a regulatory
perspective
Eulalia Olesti1,2,3*, Yoana Nuevo4,
Elena Guillen1,2, Juan Bascuas1,2,
Sara Varea1,2, Joaquín
Saez-Peñataro1,2;3, Gonzalo
Calvo1,2*
1 Department of Clinical Pharmacology, Area
Medicament, Hospital Clinic of Barcelona, Spain.
2 Clinical Pharmacology, Institut d’Investigacions
Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
3 Department of Pharmacology, University of Barcelona,
Spain.
4 Innovation Office and National Scientific Advice
Unit, Spanish Agency of Medicines and Medical Devices (AEMPS).
*Corresponding authors: olesti@clinic.cat ;